Marc Deloger

18PUBLICATIONS
239CO-AUTHORS
Cancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jan 20, 2026
Author Correction: DC subsets and states unraveled across human juxtatumoral and malignant tissues.

Kevin Mulder, Margaux Gardet, Wan Ting Kong

|Dec 16, 2025
Author Correction: DC subsets and states unraveled across human juxtatumoral and malignant tissues.

Kevin Mulder, Margaux Gardet, Wan Ting Kong

|Dec 08, 2025
DC subsets and states unraveled across human juxtatumoral and malignant tissues.

Kevin Mulder, Margaux Gardet, Wan Ting Kong

|Jul 29, 2025
Autocrine interferon poisoning mediates ADAR1-dependent synthetic lethality in BRCA1/2-mutant cancers.

Roman M Chabanon, Liudmila Shcherbakova, Magali Lacroix-Triki

|Jun 13, 2024
Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care Globally.

Javier Carmona, Elena Chavarria, Kate Donoghue

|Dec 05, 2023
Phase I/II Study of the WEE1 Inhibitor Adavosertib (AZD1775) in Combination with Carboplatin in Children with Advanced Malignancies: Arm C of the AcSé-ESMART Trial.

Susanne A Gatz, Anne C Harttrampf, Caroline Brard

Pageof 3